Filter
193
Text search:
seroprevalence
survey
Featured
Recommendations
13
New Publications
44
Language
Document type
No document type
101
Studies & Reports
38
Guidelines
27
Fact sheets
11
Manuals
8
Strategic & Response Plan
6
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
8
Tanzania
6
Latin America and the Carribbean
6
India
5
South Africa
5
Western and Central Europe
5
Asia
5
Sierra Leone
4
Cameroon
4
Middle East and North Africa
4
Africa
4
Ethiopia
3
Zambia
3
Syria
3
Brazil
3
Ukraine
3
Lesotho
3
Yemen
3
West and Central Africa
3
South–East Asia Region
3
Eastern Europe
3
Liberia
2
Nigeria
2
Senegal
2
Congo, Democratic Republic of
2
Nepal
2
Pakistan
2
Germany
2
Turkey
2
Rwanda
2
Myanmar / Burma
2
East and Southern Africa
2
Russia
2
Moldova
2
Guinea
1
Burkina Faso
1
USA
1
Saudi Arabia
1
Ghana
1
Uganda
1
Zimbabwe
1
Haiti
1
Philippines
1
Somalia
1
Iraq
1
Jordan
1
Afghanistan
1
Lebanon
1
Egypt
1
Kenya
1
Cambodia
1
Indonesia
1
Malawi
1
Mozambique
1
Sudan
1
Argentina
1
Peru
1
Eswatini/ Swaziland
1
Colombia
1
Honduras
1
Botswana
1
Bolivia
1
Libya
1
Chile
1
Eastern Europe and Central Asia
1
Venezuela
1
Palestine
1
Djibouti
1
Armenia
1
Southern Africa
1
Qatar
1
Iran
1
Vietnam
1
North America
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
66
Clinical Guidelines
18
Public Health
6
Key Resources
3
Women & Child Health
1
Pharmacy & Technologies
1
Toolboxes
HIV
38
COVID-19
29
NTDs
21
TB
15
Ebola & Marburg
6
Mental Health
6
Zika
5
Rapid Response
4
Refugee
4
Polio
2
Planetary Health
2
Malaria
2
Disability
1
Cholera
1
Conflict
1
Natural Hazards
1
Caregiver
1
2.0 Rapid Response
1
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig
...
The objective of this document is to guide the preparation and implementation of national preparedness plans for the safety of substances of human origin during outbreaks of Zika virus infection, both in affected and non-affected areas.
Regional Operational Plan 2016 FY17 Strategic Direction Summary
2 May 2016
Editorial Review
AIDS 2019, 33:1411–1420
Health Evidence Network synthesis report 53
The WHO Guide on Oral Cholera Vaccines in Mass Immunization Campaigns provides guidance on the planning and implementation of oral cholera vaccine (OCV) campaigns. It covers key aspects such as when and where to use OCVs, vaccine specifications, and recommendations for use in endemic areas, outbreak
...
Working towards better COVID-19 outcomes in the WHO European Region.From the first COVID-19 cases in Europe reported on
24 January 2020, the pandemic reached 1 million cases
within 3 months, 10 million cases within 8 months, and
100 million cases in Europe alone within 2 years. Over
the course o
...
Overcoming barriers in low- and middle-income countries
For the first time, this year’s report includes information on hepatitis C diagnostics. With a focus on selected countries with diverse HCV epidemics, the report provides updates on the various dimensions of access to HCV diagnostics and pha
...
